Please Wait
Applying Filters...
menu
    • menu
    Douglas CDMO-PSE
    News
    CDMOs' Role in Supporting US Generic Drug Development

    01 Jul 2025

    // PRESS RELEASE

    CDMOs Play Key Role in Advancing US Generic Drug Development

    01 Jul 2025

    // PRESS RELEASE

    End-to-End CDMOs: Seamless Path to Market

    20 May 2025

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Douglas CDMO

    Contact Supplier

    Website

    Bio-Europe

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/_DSPm0HktWM
    Menu

    Douglas CDMO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Douglas Pharma US

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    Bio-Europe
    Attending

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-06-15

    Douglas CDMO

    City : Warminster

    State : Pennsylvania

    Country/Area : U.S.A

    Zip : 18974

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-06-15

    Douglas CDMO

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow